184 related articles for article (PubMed ID: 17700175)
1. Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas' heart transplant recipients.
Bestetti RB; Souza TR; Lima MF; Theodoropoulos TA; Cordeiro JA; Burdmann EA
Transplantation; 2007 Aug; 84(3):441-2. PubMed ID: 17700175
[No Abstract] [Full Text] [Related]
2. Risk factors for Chagas' disease reactivation after heart transplantation.
Campos SV; Strabelli TM; Amato Neto V; Silva CP; Bacal F; Bocchi EA; Stolf NA
J Heart Lung Transplant; 2008 Jun; 27(6):597-602. PubMed ID: 18503957
[TBL] [Abstract][Full Text] [Related]
3. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C
Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695
[No Abstract] [Full Text] [Related]
4. Usefulness of sirolimus-based immunosuppression in ameliorating pre-transplant renal dysfunction in patients with Chagas' heart disease.
Bestetti RB; Theodoropoulos TA; Nakazone MA; Dourado DA; Burdmann EA
J Heart Lung Transplant; 2010 Nov; 29(11):1312-4. PubMed ID: 20719543
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
[No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil in cardiac transplantation.
Kobashigawa JA
Curr Opin Cardiol; 1998 Mar; 13(2):117-21. PubMed ID: 9593551
[TBL] [Abstract][Full Text] [Related]
8. Heart Transplantation for Chagas Cardiomyopathy.
Benatti RD; Oliveira GH; Bacal F
J Heart Lung Transplant; 2017 Jun; 36(6):597-603. PubMed ID: 28284779
[TBL] [Abstract][Full Text] [Related]
9. Heart transplant outcomes in patients with Chagas cardiomyopathy in the United States.
Benatti RD; Al-Kindi SG; Bacal F; Oliveira GH
Clin Transplant; 2018 Jun; 32(6):e13279. PubMed ID: 29744939
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.
Lietz K; John R; Schuster M; Ankersmit J; Burke E; Suciu-Foca N; Edwards N; Mancini D; Itescu S
Transplant Proc; 2002 Aug; 34(5):1828-9. PubMed ID: 12176593
[No Abstract] [Full Text] [Related]
11. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
Hunt SA
Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
[TBL] [Abstract][Full Text] [Related]
12. Survival of Heart Transplant Patients with Chagas' Disease Under Different Antiproliferative Immunosuppressive Regimens.
Furquim SR; Galbiati LC; Avila MS; Marcondes-Braga FG; Fukushima J; Mangini S; Seguro LFBDC; Campos IW; Strabelli TMV; Barone F; Paulo ARDSA; Ohe LA; Galante MC; Gaiotto FA; Bacal F
Arq Bras Cardiol; 2023 Oct; 120(10):e20230133. PubMed ID: 37909604
[TBL] [Abstract][Full Text] [Related]
13. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
Rerolle JP; Szelag JC; Le Meur Y
Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
[No Abstract] [Full Text] [Related]
14. [Mycophenolate mofetil, a possible new immunosuppresant].
Weberová J; Voboril R; Semecký V
Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
[TBL] [Abstract][Full Text] [Related]
15. Mychophenolate mofetil increased chagas disease reactivation in heart transplanted patients: comparison between two different protocols.
Bacal F; Silva CP; Bocchi EA; Pires PV; Moreira LF; Issa VS; Moreira SA; das Dores Cruz F; Strabelli T; Stolf NA; Ramires JA
Am J Transplant; 2005 Aug; 5(8):2017-21. PubMed ID: 15996254
[TBL] [Abstract][Full Text] [Related]
16. Late reactivation of Chagas' disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocardiopathy.
Marchiori PE; Alexandre PL; Britto N; Patzina RA; Fiorelli AA; Lucato LT; Rosemberg S; Pereira SL; Stolf NG; Scaff M
J Heart Lung Transplant; 2007 Nov; 26(11):1091-6. PubMed ID: 18022073
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil for the transplanted kidney?
Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
[TBL] [Abstract][Full Text] [Related]
18. A 23 years of uneventful evolution in a heart-transplanted patient with chagasic cardiomyopathy on a two-drug immunosuppressive protocol.
Andrade Vila JH; Zerbini E; Bitencourt D; Carvalho V; Macruz R; Da Silva JP; Baumgratz JF; Da Fonseca L; De Souza M; D'Andretta Neto C
Transplantation; 2009 Feb; 87(3):454-5. PubMed ID: 19202456
[No Abstract] [Full Text] [Related]
19. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
Thervet E
Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
[No Abstract] [Full Text] [Related]
20. Using polymerase chain reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation.
Maldonado C; Albano S; Vettorazzi L; Salomone O; Zlocowski JC; Abiega C; Amuchastegui M; Córdoba R; Alvarellos T
J Heart Lung Transplant; 2004 Dec; 23(12):1345-8. PubMed ID: 15607662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
